Post-discovery operating layer

Speed and regulatory rigor for pharma operations.

Premise Bio is building AI agents that learn each team's standards, review patterns, evidence expectations, and operating logic, then help regulated work move with traceability and right-first-time quality.

  • Regulatory Affairs
  • Clinical Operations
  • Medical Affairs

Platform

The AI-native layer for regulated pharma work.

Premise focuses on the operational terrain after discovery, where scientific evidence becomes controlled plans, documents, reviews, and decisions.

01

Regulatory Affairs

Assemble submission evidence, route review workflows, and preserve the reasoning behind every decision.

  • Submission package support
  • Evidence expectations and gaps
  • Traceable review operations
02

Clinical Operations

Support protocols, study startup, controlled documentation, and monitoring workflows with governed AI assistance.

  • Protocol and study document support
  • Startup and site readiness workflows
  • Operational monitoring and exceptions
03

Medical Affairs

Help teams manage evidence response, review standards, and scientific communication workflows with consistent context.

  • Evidence response workflows
  • Medical review standards
  • Scientific content governance

Design partners

Shape the operating layer for post-discovery pharma.

Premise Bio is working with pharma teams to define where AI can improve speed, rigor, and accountability across regulated execution.

We are looking for regulatory, clinical operations, and medical affairs leaders who want to help shape the first governed AI workflows.

Request an intro